Cytotoxic agents of the crinane series of amaryllidaceae alkaloids

Natural Product Communications

Volumn 7, Issue 12, 2012, Pages 1677-1688

  Nair, Jerald J ^a   Bastida, Jaume ^b   Viladomat, Francesc ^b   Van Staden, Johannes ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Alkaloids; Amaryllidaceae; Anticancer; Crinane; Cytotoxic

Indexed keywords

11 HYDROXYVITATTINE; 11 HYDROXYVITATTINE N OXIDE; 11 O ACETYLCRINAMINE; 11 O METHYLCRINAMINE; 4 METHOXY BENZOYL; 6 HYDROXYCRINAMINE; 8 O DEMETHYLMARITIDINE; ALKALOID; CRINAMINE; CRININE; CYTOTOXIC AGENT; DIHYDROCRINAMINE; GALANTAMINE; HAEMANTHAMINE; HAEMANTHIDINE; HAMAYNE; HOMOLYCORINE; ISMINE; LYCORINE; MONTANINE; NARCICLASINE; NARCIPRIMINE; NORBELLADINE; PANCRATISTATIN; PAPYRAMINE; PLANT MEDICINAL PRODUCT; TAZETTINE; TRIS PHAERIDINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VITATTINE; AMARYLLIDACEAE ALKALOID; ANTINEOPLASTIC AGENT; CRINANE;

AMARYLLIDACEAE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; BIOLOGICAL ACTIVITY; CANCER CELL CULTURE; CONCENTRATION RESPONSE; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG EFFECT; DRUG IDENTIFICATION; DRUG POTENCY; GALANTHUS NIVALIS; HUMAN; NARCISSSUS PSEUDONARCISSUS; NONHUMAN; PHARMACOPHORE; PHYTOCHEMISTRY; REVIEW; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION; ANIMAL; CHEMISTRY; DRUG SCREENING; LILIACEAE;

AMARYLLIDACEAE ALKALOIDS; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; DRUG SCREENING ASSAYS, ANTITUMOR; HUMANS; LILIACEAE; STRUCTURE-ACTIVITY RELATIONSHIP;

MLCS; MLOWN;

EID: 84875037431     PISSN: 1934578X     EISSN: 15559475     Source Type: Journal    
DOI: 10.1177/1934578x1200701234     Document Type: Review

References (81)

1. (a) Bastida J, Lavilla R, Viladomat F. (2006) Chemical and biological aspects of Narcissus alkaloids. In The Alkaloids. Cordell GA (Ed). Elsevier, Amsterdam, Netherlands, 87-179;
2. (b) Bastida J, Berkov S, Torras L, Pigni NB, De Andrade JP, Martinez V, Codina C, Viladomat F. (2011) Chemical and biological aspects of Amaryllidaceae alkaloids. In Recent Advances in Pharmaceutical Sciences. Munoz-Torrero D (Ed). Transworld Research Network, Trivandrum, India, 65-100;
3. (c) Jin Z. (2011) Amaryllidaceae and Sceletium alkaloids. Natural Product Reports, 28, 1126-1142;
4. (d) Viladomat F, Bastida J, Codina C, Nair JJ, Campbell WE. (1997) Alkaloids of the South African Amaryllidaceae. In Recent Research Developments in Phytochemistry. Vol. 1, Pandali SG (Ed). Research Signpost Publishers, Trivandrum, India. 131-171.
5. (a) Harvey AL. (1995) The pharmacology of galanthamine and its analogues. Pharmacology & Therapeutics, 68, 113-128;
6. (b) Houghton PJ, Ren Y, Howes M-J. (2006) Acetylcholinesterase inhibitors from plants and fungi. Natural Product Reports, 23, 181-199;
7. (c) Williams P, Sorribas A, Howes M-J. (2011) Natural drugs as a source of Alzheimer's drug leads. Natural Product Reports, 28, 48-77;
8. (d) Lopez S, Bastida J, Viladomat F, Codina C. (2002) Acetylcholinesterase inhibitory activity of some Amaryllidaceae alkaloids and Narcissus extracts. Life Sciences, 71, 2521-2529;
9. (e) Elgorashi EE, Stafford GI, Van Staden J. (2004) Acetylcholinesterase enzyme inhibitory effects of Amaryllidaceae alkaloids. Planta Medica, 70, 260-262;
10. (f) McNulty J, Nair JJ, Little JRL, Brennan JD, Bastida J. (2010) Structure-activity relationship studies on acetylcholinesterase inhibition in the lycorine series of Amaryllidaceae alkaloids. Bioorganic and Medicinal Chemistry Letters, 20, 5290-5294;
11. (g) Nair JJ, Van Staden J. (2012) Acetylcholinesterase inhibition within the lycorine series of Amaryllidaceae alkaloids. Natural Product Communications, 7, 959-962.
12. (a) De Leo P, Dalessandro G, De Santis A, Arrigoni O. (1973) Inhibitory effect of lycorine on cell division and cell elongation. Plant and Cell Physiology, 14, 481-486;
13. (b) Liu J, Hu W, He L, Ye M, Li Y. (2004) Effects of lycorine on HL-60 cells via arresting cell cycle and inducing apoptosis. FEBS letters, 578, 245-250;
14. (c) Liu J, Li Y, Tang LJ, Zhang GP, Hu WX. (2007) Treatment of lycorine on SCID mice model with human APL cells. Biomedicine & Pharmacotherapy, 61, 229-234;
15. (d) Li S, Chen C, Zhang H, Guo H, Wang H, Wang L, Zhang X, Hua S, Yu J, Xiao P, Li Y, Liu J, Tang L, Shi Y, Ren W, Hu W. (2007) Apoptosis induced by lycorine in KM3 cells is associated with the G0/G1 cell cycle arrest. Oncology Reports, 17, 377-384;
16. (e) Evidente A, Kornienko A. (2009) Anticancer evaluation of structurally diverse Amaryllidaceae alkaloids and their synthetic derivatives. Phytochemistry Reviews, 8, 449-459;
17. (f) Evidente A, Kireev AS, Jenkins AR, Romero AE, Steelant WFA, Van Slambrouck S, Kornienko A. (2009) Biological evaluation of structurally diverse Amaryllidaceae alkaloids and their synthetic derivatives: discovery of novel leads for anticancer drug design. Planta Medica, 75, 501-507;
18. (g) McNulty J, Nair JJ, Bastida J, Pandey S, Griffin C. (2009) Structure-activity studies on the lycorine pharmacophore: a potent inducer of apoptosis in human leukemia cells. Phytochemistry, 70, 913-919;
19. (h) Lamoral-Theys D, Decaestecker C, Mathieu V, Dubois J, Kornienko A, Kiss R, Evidente A, Pottier L. (2010) Lycorine and its derivatives for anticancer drug design. Mini-Reviews in Medicinal Chemistry, 10, 41-50;
20. (i) Evdokimov NM, Lamoral-Theys D, Mathieu V, Andolfi A, Frolova LV, Pelly SC, Van Otterlo WAL, Magedov IV, Kiss R, Evidente A, Kornienko A. (2011) In search of a cytostatic agent derived from the alkaloid lycorine: synthesis and growth inhibitory properties of lycorine derivatives. Bioorganic & Medicinal Chemistry, 19, 7252-7261.
21. (a) Pettit GR, Gaddamidi V, Cragg GM, Herald DL, Sagawa Y. (1984) Isolation and structure of pancratistatin. Journal of the Chemical Society Chemical Communications, 24, 1693-1694;
22. (b) Pettit GR, Gaddamidi V, Herald DL, Singh SB, Cragg GM, Schmidt JM, Boettner FE, Williams M, Sagawa Y. (1986) Antineoplastic agents. 120. Pancratium littorale. Journal of Natural Products, 49, 995-1002;
23. (c) Pettit GR, Pettit GR III, Backhaus RA, Boyd MR, Meerow AW. (1993) Cell growth inhibitory isocarbostyrils from Hymenocallis. Journal of Natural Products, 56, 1682-1687;
24. (d) Kornienko A, Evidente A. (2008) Chemistry, biology and medicinal potential of narciclasine and its congeners. Chemical Reviews, 108, 1982-2014;
25. (e) Ingrassia L, Lefranc F, Mathieu V, Darro F, Kiss R. (2008) Amaryllidaceae isocarbostyril alkaloids and their derivatives as promising antitumor agents. Translational Oncology, 1, 1-13;
26. (f) Ingrassia L, Lefranc F, Dewelle J, Pottier L, Mathieu V, Spiegl-Kreinecker S, Sauvage S, El Yazidi M, Dehoux M, Berger W, Van Quaquebeke E, Kiss R. (2009) Structure-activity relationship analysis of novel derivatives of narciclasine (an Amaryllidaceae isocarbostyril derivative) as potential anticancer agents. Journal of Medicinal Chemistry, 52, 1100-1114;
27. (g) Van Goietsenoven G, Hutton J, Becker J-P, Lallemand B, Robert F, Lefranc F, Pirker C, Vandenbussche G, Van Antwerpen P, Evidente A, Berger W, Prévost M, Pelletier J, Kiss R, Kinzy TG, Kornienko A, Mathieu V. (2010) Targeting of eEF1A with Amaryllidaceae isocarbostyrils as a strategy to combat melanomas. The FASEB Journal, 24, 4575-4584.
28. (a) Kekre N, Griffin C, McNulty J, Pandey S. (2005) Pancratistatin causes early activation of caspase-3 and the flipping of phosphatidyl serine followed by rapid apoptosis specifically in human lymphoma cells. Cancer Chemotherapy & Pharmacology, 56, 29-38;
29. (b) McLachlan A, Kekre N, McNulty J, Pandey S. (2005) Pancratistatin: A natural anticancer compound that targets mitochondria specifically in cancer cells to induce apoptosis. Apoptosis, 10, 619-630.
30. (a) Hudlicky T. (1996) Design constraints in practical syntheses of complex molecules: current status, case studies with carbohydrates and alkaloids, and future perspectives. Chemical Reviews, 96, 3-30;
31. (b) Rinner U, Hudlicky T. (2005) Synthesis of Amaryllidaceae constituents-an update. Synlett, 3, 365-387;
32. (c) Manpadi M, Kornienko A. (2008) Total synthesis of pancratistatin. A review. Organic Preparations and Procedures International, 40, 107-161;
33. (d) McNulty J, Nair JJ, Singh M, Crankshaw DJ, Holloway AC, Bastida J. (2009) Selective cytochrome P450 3A4 inhibitory activity of Amaryllidaceae alkaloids. Bioorganic and Medicinal Chemistry Letters, 19, 3233-3237;
34. (e) McNulty J, Nair JJ, Singh M, Crankshaw DJ, Holloway AC, Bastida J. (2010) Cytochrome P450 3A4 inhibitory activity studies within the lycorine series of alkaloids. Natural Product Communications, 5, 1195-1200;
35. (f) McNulty J, Thorat A, Vurgun N, Nair JJ, Makaji E, Crankshaw DJ, Holloway AC, Pandey S. (2011) Human cytochrome P450 liability studies of trans-dihydronarciclasine: a readily available, potent and selective cancer cell growth inhibitor. Journal of Natural Products, 74, 106-108.
36. (a) McNulty J, Mo R. (1998) Diastereoselective intramolecular nitroaldol entry to lycoricidine alkaloids. Journal of the Chemical Society Chemical Communications, 933-934;
37. (b) McNulty J, Mao J, Gibe R, Mo R, Wolf S, Pettit GR, Herald DL, Boyd MR. (2001) Studies directed towards the refinement of the pancratistatin cytotoxic pharmacophore. Bioorganic & Medicinal Chemistry Letters, 11, 169-172;
38. (c) Pettit GR, Melody N, Herald DL. (2001) Antineoplastic agents. 450. Synthesis of (+)-pancratistatin from (+)-narciclasine as relay. Journal of Organic Chemistry, 66, 2583-2587;
39. (d) Hudlicky T, Rinner U, Gonzales D, Akgun H, Schilling S, Siengalewicz P, Martinot TA, Pettit GR. (2002) Total synthesis and biological evaluation of Amaryllidaceae alkaloids: narciclasine, ent-7-deoxypancratistatin, regioisomer of 7-deoxypancratistatin, 10b-epi-deoxypancratistatin, and truncated derivatives. Journal of Organic Chemistry, 67, 8726-8743;
40. (e) Rinner U, Hillebrenner HL, Adams DR, Hudlicky T, Pettit GR. (2004) Synthesis and biological activity of some structural modifications of pancratistatin. Bioorganic & Medicinal Chemistry Letters, 14, 2911-2915;
41. (f) Rinner U, Hudlicky T, Gordon H, Pettit GR. (2004) A P-carboline-1-one mimic of the anticancer Amaryllidaceae constituent pancratistatin: synthesis and biological evaluation. Angewandte Chemie International Edition in English, 43, 5342-5346;
42. (g) McNulty J, Larichev V, Pandey S. (2005) A synthesis of 3-deoxydihydrolycoricidine: refinement of a structurally minimum pancratistatin pharmacophore. Bioorganic & Medicinal Chemistry Letters, 15, 5315-5318;
43. (h) Pettit GR, Eastham SA, Melody N, Orr B, Herald DL, McGregor J, Knight JC, Doubek DL, Pettit GR III, Garner LC, Bell JA. (2006) Isolation and structural modification of 7-deoxynarciclasine and 7-deoxy-trans- dihydronarciclasine. Journal of Natural Products, 69, 7-13;
44. (i) McNulty J, Nair JJ, Griffin C, Pandey S. (2008) Synthesis and biological evaluation of fully functionalized seco-pancratistatin analogues. Journal of Natural Products, 71, 357-363.
45. (a) Ghosal S, Saini KS, Razdan S. (1985) Crinum alkaloids: their chemistry and biology. Phytochemistry, 24, 2141-2156;
46. (b) Fennell CW, Van Staden J. (2001) Crinum species in traditional and modern medicine. Journal of Ethnopharmacology, 78, 15-26;
47. (c) Tram NTM, Titorenkova TV, Bankova VS, Handjieva NV, Popov SS. (2002) Crinum L. (Amaryllidaceae). Fitoterapia, 73, 183-208.
48. (a) Ceriotti G. (1967) Narciclasine: an antimitotic substance from Narcissus bulbs. Nature, 213, 595-596;
49. (b) Jimenez A, Santos A, Alonso G, Vazquez D. (1976) Inhibitors of protein synthesis in eukaryotic cells. Comparative effects of some Amaryllidaceae alkaloids. Biochimica et Biophysica Acta, 425, 342-348.
50. Furusawa E, Irie H, Combs D, Wildman WC. (1980) Therapeutic activity of pretazettine on Rauscher leukemia: comparison with the related Amaryllidaceae alkaloids. Experimental Chemotherapy, 26, 36-45.
51. Pettit GR, Gaddamidi V, Goswami A, Cragg GM. (1984) Antineoplastic agents. 99. Amaryllis belladonna. Journal of Natural Products, 47, 796-801.
52. Ghosal S, Saini KS, Arora VK. (1984) 1, 2-Epoxyambelline, an immunostimulant alkaloid from Crinum latifolium. Journal of Chemical Research (S), 232-233.
53. Ghosal S. (1986) Chemical constituents of Amaryllidaceae. Part 24. Crinafoline and crinafolidine, two antitumor alkaloids from Crinum latifolium. Journal of Chemical Research (S), 312-313.
54. Abd El Hafiz MA, Ramadan MA, Jung ML, Beck JP, Anton R. (1991) Cytotoxic activity of Amaryllidaceae alkaloids from Crinum augustum and Crinum bulbispermum. Planta Medica, 57, 437-439.
55. Likhitwitayawuid K, Angerhofer CK, Chai H, Pezzuto JM, Cordell GA, Ruangrungsi N. (1993) Cytotoxic and antimalarial alkaloids from the bulbs of Crinum amabile. Journal of Natural Products, 56, 1331-1338.
56. Antoun MD, Mendoza NT, Rios YR, Proctor, GR, Wickramaratne DBM, Pezzuto JM, Kinghorn AD. (1993) Cytotoxicity of Hymenocallis expansa alkaloids. Journal of Natural Products, 56, 1423-1425.
57. Lin L-Z, Hu S-F, Chai H-B, Pengsuparp T, Pezzuto JM, Cordell GA, Ruangrungsi N. (1995) Lycorine alkaloids from Hymenocallis littoralis. Phytochemistry, 40, 1295-1298.
58. Weniger B, Italiano L, Beck JP, Bastida J, Bergoñon S, Codina C, Lobstein A, Anton R. (1995) Cytotoxic activity of Amaryllidaceae alkaloids. Planta Medica, 61, 77-79.
59. Campbell WE, Nair JJ, Gammon DW, Bastida J, Codina C, Viladomat F, Smith PJ, Albrecht CF. (1998) Cytotoxic and antimalarial alkaloids from Brunsvigia littoralis. Planta Medica, 64, 91-93.
60. Nair JJ, Campbell WE, Gammon DW, Albrecht CF, Viladomat F, Codina C, Bastida J. (1998) Alkaloids from Crinum delagoense. Phytochemistry, 49, 2539-2543.
61. Campbell WE, Nair JJ, Gammon DW, Codina C, Bastida J, Viladomat F, Smith PJ, Albrecht CF. (2000) Bioactive alkaloids from Brunsvigia radulosa. Phytochemistry, 53, 587-591.
62. Abou-Donia AH, Amer ME, Darwish FA, Kassem FF, Mammoda HM, Abdel-Kader MS, Zhou B-N, Kingston DGI. (2002) Two new alkaloids of the crinane series from Pancratium sickenbergeri. Planta Medica, 68, 379-381.
63. Hohmann J, Forgo P, Molnár J, Wolfard K, Molnár A, Thalhammer T, Mathé I, Sharples D. (2002) Antiproliferative Amaryllidaceae alkaloids isolated from the bulbs of Sprekelia formosissima and Hymenocallis x festalis. Planta Medica, 68, 454-457.
64. Phan TS, Tran BD, Bach D, Phan MG, Nguyen TM, Hoang TH, Le MH. (2003) Investigation of antimicrobial and cytotoxic properties of alkaloids from some species of Crinum in Vietnam. Tap Chi Duoc Hoc, 4, 18-21.
65. Nair JJ, Campbell WE, Brun R, Viladomat F, Codina C, Bastida J. (2005) Alkaloids from Nerine filifolia. Phytochemistry, 66, 373-382.
66. (a) McNulty J, Nair JJ, Codina C, Bastida J, Pandey S, Gerasimoff J, Griffin C. (2007) Selective apoptosis-inducing activity of crinum-type Amaryllidaceae alkaloids. Phytochemistry, 68, 1068-1074;
67. (b) Griffin C, Sharda N, Sood, D, Nair JJ, McNulty J, Pandey S. (2007) Selective cytotoxicity of pancratistatin-related natural Amaryllidaceae alkaloids: evaluation of the activity of two new compounds. Cancer Cell International, 7, 10-16.
68. Silva AFS, De Andrade JP, Machado KRB, Rocha AB, Apel MA, Sobral MEG, Henriques AT, Zuanazzi JAS. (2008) Screening for cytotoxic activity of extracts and isolated alkaloids from bulbs of Hippeastrum vittatum. Phytomedicine, 15, 882-885.
69. Sun Q, Shen Y-H, Tian J-M, Tang J, Su J, Liu R-H, Li H-L, Xu X-K, Zhang W-D. (2009) Chemical constituents of Crinum asiaticum L. var. sinicum Baker and their cytotoxic activities. Chemistry & Biodiversity, 6, 1751-1757.
70. McNulty J, Nair JJ, Bastida J, Pandey S, Griffin C. (2009) Structure activity studies on the crinane alkaloid apoptosis-inducing pharmacophore. Natural Product Communications, 4, 483-488.
71. Simpson CD, Anyiwe K, Schimmer AD. (2008) Anoikis resistance and tumor metastasis. Cancer Letters, 272, 177-185.
72. Van Goietsenoven G, Andolfi A, Lallemand B, Cimmino A, Lamoral-Theys D, Gras T, Abou-Donia A, Dubois J, Lefranc F, Mathieu V, Kornienko A, Kiss R, Evidente A. (2010) Amaryllidaceae alkaloids belonging to different structural subgroups display activity against apoptosis-resistant cancer cells. Journal of Natural Products, 73, 1223-1227.
73. Osorio EJ, Berkov S, Brun R, Codina C, Viladomat F, Cabezas F, Bastida J. (2010) In vitro antiprotozoal activity of alkaloids from Phaedranassa dubia (Amaryllidaceae). Phytochemistry Letters, 3, 161-163.
74. Kaya GI, Sarikaya B, Onur MA, Somer NU, Viladomat F, Codina C, Bastida B, Lauinger IL, Kaiser M, Tasdemir D. (2011) Antiprotozoal alkaloids from Galanthus trojanus. Phytochemistry Letters, 4, 301-305.
75. Berkov S, Romani S, Herrera M, Viladomat F, Codina C, Momekov G, Ionkova I, Bastida J. (2011) Antiproliferative alkaloids from Crinum zeylanicum. Phytotherapy Research, 25, 1686-1692.
76. Jitsuno M, Yokosuka A, Hashimoto K, Amano O, Sakagami H, Mimaki Y. (2011) Chemical constituents of Lycoris albiflora and their cytotoxic activities. Natural Product Communications, 6, 187-192.
77. Luchetti G, Johnston R, Mathieu V, Lefranc F, Hayden K, Andolfi A, Lamoral-Theys D, Reisenauer MR, Champion C, Pelly SC, van Otterlo WAL, Magedov IV, Kiss R, Evidente A, Rogelj S, Kornienko A. (2012) Bulbispermine: a crinine-type Amaryllidaceae alkaloid exhibiting cytostatic activity toward apoptosis-resistant glioma cells. ChemMedChem, 7, 815-822.
78. Adewusi EA, Fouche G, Steenkamp V. (2012) Cytotoxicity and acetylcholinesterase inhibitory activity of an isolated crinine alkaloid from Boophone disticha (Amaryllidaceae). Journal of Ethnopharmacology, 143, 572-578.
79. Nair JJ, Rárová L, Strnad M, Bastida J, Van Staden J. (2012) Apoptosis-inducing effects of distichamine and narciprimine, rare alkaloids of the plant family Amaryllidaceae. Bioorganic and Medicinal Chemistry Letters, 22, 6195-6199.
80. (a) Opferman JT, Letai A, Beard C, Sorcinelli MD, Ong CC, Korsmeyer SJ. (2003) Development and maintenance of B and T lymphocytes require antiapoptotic MCL-1. Nature, 426, 671-676;
81. FBW7 regulates cellular apoptosis by targeting MCL1 for ubiquitylation and destruction. Nature, 471, 104-109.